PAREXEL Named to the 2016 Forbes America’s Best Employers List
March 23 2016 - 2:40PM
Business Wire
PAREXEL International Corporation (NASDAQ: PRXL), a leading
global biopharmaceutical services organization, today announced
that Forbes named the Company to the magazine’s America’s “Best
Employers” list for 2016. The list features the top 500 U.S.
employers with more than 5,000 employees as rated by 30,000
employees in an independent survey.
“We are honored to be named as one of Forbes magazine’s ‘Best
Employers’ in the U.S. At PAREXEL, we have a desire to make a
difference in the lives of people – and that starts with our own
employees,” said Michelle Graham, Corporate Vice President and
Chief Human Resources Officer, PAREXEL. “At PAREXEL, our employees
are the key to our success. PAREXEL and our clients have a shared
mission: to prevent and cure disease by delivering important new
medicines and therapies to the patients who need them. PAREXEL
accomplishes this important goal through the expertise, experience,
innovation and commitment of our employees around the world.”
PAREXEL’s commitment to employees is reflected in the Company’s
high performance culture where employees are empowered to speak
openly, take ownership, focus on clients, and drive business
results, regardless of their role in the organization. The Company
also offers employees best-in-class training programs and
professional growth opportunities.
About the Forbes America’s Best Employers List
Methodology
Now in its second year, the Forbes ranking of America’s Best
Employers is drawn from an online survey of more than 30,000
employees at companies with at least 1,000 people. The survey was
conducted with global digital data collection partners who use
innovative technology and proven sampling methodologies to
facilitate a deep understanding of consumer opinions and behavior.
Participation in the survey was voluntary, and respondents were
recruited from thousands of sources to maximize reach and
representation. The mix of respondents (gender, age, region, and
ethnicity) in the sample represents American employees. Each
employee surveyed was asked to rank both his own employer and other
employers in the same industry sector.
About PAREXEL International
PAREXEL International Corporation is a leading global
biopharmaceutical services organization, providing a broad range of
expertise-based contract research, consulting, medical
communications, and technology solutions and services to the
worldwide pharmaceutical, biotechnology and medical device
industries. Committed to providing solutions that expedite
time-to-market and peak-market penetration, PAREXEL has developed
significant expertise across the development and commercialization
continuum, from drug development and regulatory consulting to
clinical pharmacology, clinical trials management, medical
education and reimbursement. PAREXEL Informatics provides advanced
technology solutions, including medical imaging, to facilitate the
clinical development process. Headquartered near Boston,
Massachusetts, PAREXEL has offices in 77 locations in 51 countries
around the world, and had approximately 18,200 employees in the
second quarter. For more information about PAREXEL International
visit www.PAREXEL.com.
PAREXEL is a registered trademark of PAREXEL International
Corporation. All other trademarks are the property of their
respective owners.
This release contains “forward-looking” statements regarding
future results and events. For this purpose, any statements
contained herein that are not statements of historical fact may be
deemed forward-looking statements. Without limiting the foregoing,
the words “believes,” “anticipates,” “plans,” “expects,” “intends,”
“appears,” “estimates,” “projects,” “will,” “would,” “could,”
“should,” “targets,” and similar expressions are also intended to
identify forward-looking statements. The forward-looking statements
in this release involve a number of risks and uncertainties. Such
factors and others are discussed in the section entitled “Risk
Factors” of the Company’s most recent Annual Report on Form 10-K
and subsequent quarterly reports on Form 10-Q as filed with the
Securities and Exchange Commission, which “Risk Factors” discussion
is incorporated by reference in this press release. The Company
specifically disclaims any obligation to update these
forward-looking statements in the future. These forward-looking
statements should not be relied upon as representing the Company’s
estimates or views as of any date subsequent to the date of this
press release.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160323006425/en/
PAREXEL InternationalCristi Barnett+1
781-434-4019Cristi.Barnett@PAREXEL.comorPAN CommunicationsMatthew
Briggs+1 617-502-4300PAREXEL@pancomm.com
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Apr 2023 to Apr 2024